ReShape Lifesciences Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$9.28 | -$9.28 | -$9.28 |
| Q2 2024 | 1 | -$6.96 | -$6.96 | -$6.96 |
| Q3 2024 | 1 | -$5.80 | -$5.80 | -$5.80 |
| Q4 2024 | 1 | -$4.06 | -$4.06 | -$4.06 |
ReShape Lifesciences Inc. Earnings Date And Information
ReShape Lifesciences Inc. last posted its earnings results on Wednesday, May 15th, 2024. The company reported $-5.23 earnings per share for the quarter, missing analysts' consensus estimates of $-0.16 by $5.07. The company had revenue of 2.29 M for the quarter and had revenue of 8.68 M for the year. ReShape Lifesciences Inc. has generated $-111 earnings per share over the last year ($-110.88 diluted earnings per share) and currently has a price-to-earnings ratio of -0.4. ReShape Lifesciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based on prior year's report dates.
ReShape Lifesciences Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$3.11 | $2.51 M | $2.29 M | ||
| 08/14/2024 | Q2 2024 | -$3.67 | $2.21 M | $1.97 M | ||
| 05/15/2024 | Q1 2024 | -$0.16 | -$5.42 | -5.26 | $1.94 M | |
| 04/01/2024 | Q4 2023 | -$0.18 | -$4.20 | -4.02 | $1.98 M | |
| 11/08/2023 | Q3 2023 | -$59.16 | $2.40 M | $2.16 M | ||
| 08/07/2023 | Q2 2023 | -$1.79 | -$62.64 | -60.85 | $2.61 M | $2.25 M |
| 05/15/2023 | Q1 2023 | -$4.21 | -$90.48 | -86.27 | $2.29 M | |
| 04/17/2023 | Q4 2022 | -$10.00 | -$2,056.68 | -2046.68 | $3.11 M | |
| 11/14/2022 | Q3 2022 | -$17.75 | -$1,566.58 | -1548.83 | $3.62 M | $2.80 M |
| 08/19/2022 | Q2 2022 | -$18.00 | -$1,418.10 | -1400.1 | $3.41 M | $2.89 M |
| 05/23/2022 | Q1 2022 | -$17.00 | -$1,285.28 | -1268.28 | $2.44 M | |
| 04/08/2022 | Q4 2021 | -$5,757.08 | $3.14 M | |||
| 11/12/2021 | Q3 2021 | -$3,003.82 | $3.87 M | $3.71 M | ||
| 08/16/2021 | Q2 2021 | -$2,484.72 | $3.50 M | $3.53 M | ||
| 05/12/2021 | Q1 2021 | -$26.50 | -$3,598.32 | -3571.82 | $3.22 M | |
| 03/12/2021 | Q4 2020 | -$22.00 | -$6,303.44 | -6281.44 | $3.21 M | |
| 11/06/2020 | Q3 2020 | -$610.54 | -$3,823.36 | -3212.82 | $3.60 M | |
| 07/30/2020 | Q2 2020 | -$1,512.06 | $1.70 M | |||
| 06/18/2020 | Q1 2020 | -$1,822.36 | $2.79 M | |||
| 02/27/2020 | Q4 2019 | -$11,555.34 | $4.05 M |
ReShape Lifesciences Inc. Earnings: Frequently Asked Questions
-
When is ReShape Lifesciences Inc.'s earnings date?
ReShape Lifesciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based off last year's report dates.
-
How can I listen to ReShape Lifesciences Inc.'s earnings conference call?
The conference call for ReShape Lifesciences Inc.'s latest earnings report can be listened to online.
-
How can I read ReShape Lifesciences Inc.'s conference call transcript?
The conference call transcript for ReShape Lifesciences Inc.'s latest earnings report can be read online.
-
How much revenue does ReShape Lifesciences Inc. generate each year?
ReShape Lifesciences Inc. (:RSLS) has a recorded annual revenue of $8.68 M.
-
How much profit does ReShape Lifesciences Inc. generate each year?
ReShape Lifesciences Inc. (:RSLS) has a recorded net income of $8.68 M. ReShape Lifesciences Inc. has generated $-110.88 earnings per share over the last four quarters.
-
What is ReShape Lifesciences Inc.'s price-to-earnings ratio?
ReShape Lifesciences Inc. (:RSLS) has a price-to-earnings ratio of -0.4 and price/earnings-to-growth ratio is -0.
